Pay in 4 interest-free payments of $7.39 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
The recommended clinical dose used in the Egrifta label is 2 mg administered subcutaneously once daily
The study was a randomized, double-blind, placebo-controlled trial carried out at 51 sites in Japan
10.1080/10408398.2010.501533 137 MontserratP.MayteB.CintaB.SalvadM
Reconstitution and Administration Routes Discussed in Literature GHK-Cu administration in literature includes topical creams, gels, wound dressings, microneedle-assisted delivery models, liposomal formulations, and injectable-route regulatory discussion [2], [7], [8], [14], [15]
US$ 20.30
US$ 20.59
US$ 28.11
